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Summary 
Many human neurodegenerative diseases are characterized by the idiopathic death of cells nar- 
rowly restricted to a subset of neurons in a specific functional neuroanatomic system. Few in 
vivo models exist for the analysis  of these types of degeneration. This report documents the 
death of sympathetic neurons resident in the superior cervical ganglia of rats after exposure to 
an exogenous chemical agent, the drug gnanethidine, as being mediated by natural killer (NK) 
cells. This is the first in vivo model of a disorder of the nervous system in which NK cells appear 
to be the principal effector cell, and thus could serve a central role in dissecting the normal and 
pathological function of NK cells. In addition, this pathogenetic mechanism appears to represent 
a novel type of autoimmune reaction that could have a direct bearing on a number of human illnesses. 
N 
'K  cells  are  a  subpopulation  of CD3-,  LGL  whose 
function to date has been defined by their ability to 
mediate the in vitro destruction of certain neoplastic or vitally 
infected cells in a rapid, non-MHC restricted fashion (1-3). 
NK cells can be phenotypically identified by their character- 
istic expression of cell surface markers which in the rat in- 
dude  3.2.3  (NKR-P1),  CD8,  and  asialo-GM,  (4-7).  Al- 
though there is data to support a role for NK cells in the 
protection of the individual from infections and neoplasms 
(8-13), their role as a primary effector cell causing in vivo, 
autoimmune tissue destruction remains controversial (14). Re- 
cently, a mAb, 3.2.3,  was developed (6,  7) that recognizes 
all rat NK cells, and which selectively depletes recipient rats 
of circulating NK cells without affecting circulating lym- 
phocytes or monocytes (6).  This reagent, which binds to 
NKR-P1,  a cell membrane-signaling molecule for NK cell 
activation (15, 16), makes it possible to specifically define the 
in vivo role of NK cells in various disease  models. 
Guanethidine is an adrenergic neuron-blocking agent whose 
pharmacology and metabolism have been extensively studied 
(17-19).  In 1971, Erkanko and Erkanko (20)  reported that 
this drug induced destruction of sympathetic neurons in the 
superior cervical ganglia (SCG) 1, of neonatal and adult rats, 
while sparing nonsympathetic neurons. Subsequently, this 
model of selective sympathectomy has been extensively charac- 
terized (21-26). 
Observations by Manning et al.  (27, 28) concerning the 
1 Abbreviation used in this paper: SCG, superior cervical ganglia. 
mechanism of this sympathectomy determined that it was 
at least in part mediated by cellular elements of the immune 
system, and could be blocked by lethal irradiation or cy- 
dophosphamide administration. One curious feature of this 
immune-mediated destruction in rats was that it occurred 
more rapidly than typical T cell-mediated reactions. Cellular 
infiltrate and neuronal death could be seen a few days after 
initiation of treatment in neonatal rats, and was virtuaUy com- 
plete by 7 d (26). Moreover, athymic rats were as susceptible 
as euthymic rats to this neuronal destruction (24,  25). 
Prior studies in our laboratory have shown that the prin- 
cipal infiltrating cell type during guanethidine-induced sym- 
pathectomy is a CD8 +, lymphocyte-like cell (26).  This ob- 
servation,  coupled  with  the  aforementioned phenomena 
associated  with this system, lead us to the hypothesis that 
NK cells might be central to its pathogenesis.  This study 
was designed to evaluate morphologically and in vivo the role 
of rat NK cells in gnanethidine sympathectomy. 
Materials  and Methods 
Animals.  Pregnant Fisher 344 rats were obtained from Charles 
River Breeding Laboratories, Inc. (Wilmington, MA). The rats 
were housed separately  with free access  to water and rat chow. When 
the  pups  were delivered, they were left  with  their  mothers 
throughout the experiment. 
Induction of Sympathectomy.  Beginning at 1 wk of age, rat pups 
were given daily subcutaneous injections of 100 #1 of guanethidine 
monosulfate (Sigma Chemical Co., St. Louis, MO) dissolved in 
PBS at a dose of 25.0 mg/kg for 5 d. Control animals received 
saline injections. All pups were kilhd 24 h after the last injection, 
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histochemistry and histological evaluation. 
Antibody Treatment.  The antibodies employed in an attempt to 
prevent the neuronal necrosis  are listed in Table 1. The majority 
of the antibodies used were routine IgGs directed specifically to 
rat antigens. All murine antibodies were obtained from Bioproducts 
for Science (Indianapolis,  IN), except for the 3.2.3 antibody which 
was supplied (by J. Hiserodt) as ascites. The antiasialo-GM1  was 
a rabbit antiserum (Wako Chemicals, Dallas, TX). All of these an- 
tibodies were diluted in PBS to a protein concentration of 1.0 mg/ml, 
and specific  pups were given 0.5 ml of the antibody by intraperitoneal 
injection on the day before the first and at the time of the third 
guanethidine injection. As a control for the antibody injections, 
0.5-ml injections of normal mouse serum diluted 1:5 with PBS 
were given at similar  times. 
Tissue Processing.  At the time of  killing, the SCGs were removed 
from each rat pup. One was fixed in buffered 3% glutaraldehyde 
and embedded in plastic resin for histological and ultrastructural 
studies (26). The other SCG was snap frozen in OCT (Miles Labora- 
tories Inc., Elkhart, IN) for immunohistochemical analysis. Im- 
munohistochemistry was performed on 5.0-#m thick sections by 
a previously detailed method (29).  Both 1-#m-thick plastic  sec- 
tions and immunohistochemically stained  sections from each rat 
were assessed for the presence and extent of inflammation and neu- 
ronal death (Table 2). In addition,  the spleen  and other ganglia 
were removed from selected pups for immunohistochemical anal- 
ysis to detect the effectiveness of the antibodies in depleting the 
NK cells or for the presence of inflammation at other ganglionic 
sites. 
Results  and  Discussion 
Guanethidine produced the expected, widespread neuronal 
destruction  in the SCG within  5  d  (Fig.  1 A).  As shown 
in Table 2, normal mouse serum (Fig. 2 A), as well as anti- 
bodies against  T  cell epitopes  (including  CD5  and CD4), 
macrophage/monocytic molecules,  or MHC  class  I  and  II 
antigens, all failed to protect the rat pups from the guanethi- 
dine effect. Complete or near complete protection of pups 
from guanethidine-induced neuronal death was provided by 
either a rabbit antiserum against asialo-GM1, or a combina- 
tion of 3.2.3 and antiasialo-GM1. Normal mouse serum had 
no effect. The antibodies 3.2.3 and OX-8 alone protected to 
an extent greater than any of the other mAbs.  In 4  of 12 
pups given 3.2.3 treatment, this mAb completely prevented 
both neuronal killing and cellular inflammation of the gan- 
glia  (Fig.  1  B).  The efficacy of both  antiasialo-GMl  and 
3.2.3 antibodies in depleting the NK cells of the rats has been 
previously documented (6), the latter by inducing degranu- 
lation via the NKR-P1  membrane-signaling  molecule (15, 
16). In this study, these antibodies, alone or together, exten- 
sively reduced or rendered undetectable the splenic popula- 
tion of NK  (3.2.3  positive) cells in treated pups. 
Immunohistochemical  analysis  of the  damaged  ganglia 
showed a marked infiltrate by 3.2.3 positive NK cells in all 
the groups that exhibited neuronal destruction and inflam- 
mation  (Fig.  1 C).  In addition  to NK cells,  other CD4 + , 
CD8 +,  and  macrophage/monocytic  (CDllb/c)  cells  were 
present. In the ganglia of animals treated with 3.2.3 and/or 
antiasialo GM1, 3.2.3 positive cells were very sparse or un- 
detectable. Moreover, the other attendant cellular components 
of the inflammatory infiltrate were likewise reduced or elim- 
inated. 
The data obtained by these experiments strongly suggest 
that the guanethidine-induced death of neurons in the SCG 
is mediated by cells morphologically and phenotypically con- 
sistent with the NK lineage. Moreover, this destruction can 
be substantially inhibited by antibodies known to interfere 
with  NK  cell  function.  One  of  the  striking  features  of 
guanethidine-induced sympathectomy is that it is predomi- 
nantly restricted to SCG sympathetic ganglion cells, whereas 
sympathetic ganglion cells in the prevertebral superior mesen- 
teric and celiac ganglia exhibit far less cell death (21, 23, 26). 
There are species and strain variations in sensitivity to the 
Table  1.  Antibodies Used 
Antibody  NK  CD8 +  CD4 *  Monocyte/ 
designation  Specificity  cells  T  cell  T  cell  Macrophage  B cells 
3.2.3  rat NK cells  +  +  +  .... 
antiAsialo-GMt*  + +  +  +  -  +  +  - 
OX-8  rat CD8  +  +  +  +  +  -  -  - 
W3/25  rat CD4  -  -  +  +  +  +  - 
OX-42  rat CR3  (CD11b/c)  +  -  -  +  + +  - 
OX-19  rat CD5  -  +  +  +  +  -  - 
OX-52  peripheral T  cells  +  + +  +  +  -  - 
OX-18  rat MHC class I  +  +  +  +  +  +  + +  +  + 
OX-6  rat MHC class II  -  -+  +  +  + +  +  + 
" This is a rabbit antiserum produced by Wako Chemicals USA, Inc. (Dallas TX, code #986-10001.). 100 #1 of this antiserum injected into an 
adult BALB/c mouse 72 h before testing completely inhibits YAC-1 target cell killing by the NK cells obtained from that mouse. 
812  Natural Killer Cell-mediated Neuronal Killing Figure 1.  Photomicrographs  of SCG from rat pups. (.4) SCG from a rat receiving guanethidine and normal mouse serum as a control (graded 3 
for both neuron loss and inflammation).  (B) SCG from a rat pup given guanethidine and 3.2.3. Note the extent of protection and lack of inflammation 
in the ganglion of the pup in which NK cells have been depleted. (C") Ganglion from a pup during the acute phase of neuronal destruction  which 
has been immunohistochemicaUy stained with the anti-NKK-Pl antibody 3.2.3.  Note the number of NK cells identified in the inflamed ganglion. 
(D) SCG from a normal, untreated pup,  age matched with the treated  groups  (histologically normal ganglion).  A, B, and D were obtained from 
toluidine blue-stained,  1-#m-thick  plastic sections,  x250. 
drug suggesting a strong effect of the subject's genetic com- 
position on the process (23, 26). Thus, the guanethidine model 
of sympathetic neuron killing is a useful system for studying 
neuroanatomicaUy specific cell death.  This  study also pro- 
vides evidence for the existence of a unique mechanism of 
autoimmunity: an exogenously/chemicaUy induced alteration 
in a specific subset of bodily cells that targets them for NK 
ceU-mediated killing. 
Immunohistochemical and ultrastructural studies previously 
performed in our laboratories support a potential role for NK 
cells in this process (26). As evidence for this hypothesis, im- 
munohistochemical analyses of SCG from rat  pups under- 
going guanethidine-induced sympathectomy revealed that a 
large proportion of the CD8 + cells in the ganglion 5-7 d 
after the initiation of guanethidine-during the stage of neu- 
ronal destruction-was  also positive with the selective NK 
cell marker  3.2.3  (Fig.  1)  as  well as for the expression of 
asialo-GM1,  also  characteristic  of NK  cells.  However,  im- 
munofluorescent double-hbding of an affected ganglion simul- 
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taneously with 3.2.3 and anti-CD3 (expressed on all mature 
T cells [30]) mAbs revealed that the majority of the infiltrating 
CD8 +  cells  were  3.2.3  positive,  but  CD3  negative,  thus 
confirming their NK cell phenotype (31-33). Normal rat SCGs 
(Fig. 1 D) contain neither T cells nor 3.2.3 positive NK cells. 
Ultrastructural examination of ganglia in which neurons were 
degenerating demonstrated the presence of large lymphocy- 
toid cells with granular cytoplasmic inclusions which were 
not a normal cellular constituent of the ganglia (26). These 
LGL cells in the rat  are typical of cells with natural  killer 
function (4-7,  13).  Moreover, in the SCG they could occa- 
sionally be found within the neuronal Schwann cell sheath 
in intimate apposition to neurons (Fig. 2). The present study 
is consistent with a cytotoxic role of NK cells in this neu- 
roanatomically restricted system of neuronal killing by using 
antibodies directed to various hematogenous cell types to selec- 
tively inactivate  specific cellular participants. 
Since NK cells do not possess the antigen-specific receptor 
complex characteristic of T  and B lymphocytes, the recogni- Table  2.  Experimental  Protocol and Results 
Number of  Neuronal  P  Inflammatory  P 
Antibodies injected*  rat pups  death*  valuel  infiltratelt  value~ 
Controls: 
No antibody and no guanethidineS  8  0.03  _+  0.13  <0.001  0.2  _+  0.1  <0.001 
Normal mouse serum  +  guanethidine  9  2.5  _+  0.5  -  2.5  _+  0.6  - 
Test groups (all with guanethidine): 
3.2.3  12  0.7  _+  0.7  <0.001  1.0  _+  1.0  <0.005 
antiasialo  GM1  8  0.5  _+  0.4  <0.001  0.4  _+  0.4  <0.001 
3.2.3  plus  antiasialo  GMI  6  0.4  _+  0.3  <0.001  0.5  _+  0.3  <0.001 
OX-8  5  0.8  _+  0.6  <0.001  1.0  _+  0.6  <0.001 
anti T-cell (OX-19,  OX-52  plus W3/25)  5  2.9  _+  0.3  NS  3.0  _+  0.2  NS 
OX-18  2  1.9  _+  0.3  NS  2.0  _+  0.4  NS 
OX-6  3  2.1  +  0.7  NS  2.3  _+  0.4  NS 
OX-42  2  1.8  _+  0.5  NS  2.1  _+  0.3  NS 
* mAbs were obtained as ascites, and the protein concentration adjusted to 1 mg total protein/ml. The antiserum against asialo-GM1 was recon- 
stituted according to manufacturer's instructions.  All antibodies were given by intraperitoneal injection of 100/~g of the antibody indicated in a 
total volume of 0.5 ml on days -  1 and  + 2. The first guanethidine injection was given on day 7 of life, and continued daily. The pups were killed 
24 h after the 5th injection. 
* 1-/xm-thick plastic sections of all experimental ganglia (Sincluding controls from normal rat pups) were scored blindly by two investigators using 
a semiquantitative scale. The scale ranged from 0 to 3, with 0 indicating no cell death; 1, scattered (<10%) dead neurons; 2, clusters of dead neurons; 
and 3, widespread or total neuronal destruction. The mean +  SD was derived form the aggregate values from both observers for all pups in that group. 
II As with neuronal death, the presence of infiltrating T cells, NK cells, and monocytes was judged on a semiquantitative scale of 0-3 ranging from 
no detectable cells to confluent inflammation. 
I p values were computed for two independent samples of unequal size and unknown  population variance using a two-tailed Student's t test. The 
P values represent the significance of the statistical difference of the values in the column to the left, between pups receiving guanethidine plus normal 
mouse serum, and the group for which the value is given. NS, P >0.05. 
tion system and the "antigen" or substance being identified 
as foreign by NK cells in the ganglia after gnanethidine treat- 
ment, remains unknown (3, 31, 34). Nevertheless, their rec- 
ognition  of targets does  not  appear to follow  the  classical 
rules of induction and memory pertaining to other lympho- 
cyte classes (1-3).  At  this  time,  it cannot be determined  if 
the NK-mediated destruction  is by direct neuronal cytotox- 
icity,  or whether  the NK cells produce killing via another 
more indirect immune mediated process requiring the pres- 
ence of additional inflammatory cell types. However, a cen- 
tral role for the NK cell in this process seems to be supported. 
The precise molecular events occurring in the ganglion cells 
which render them susceptible to this cytotoxic mechanism 
have yet  to be identified. 
Among human neurological disorders, many of the most 
enigmatic are those in the group of so-called "neurodegener- 
ative diseases" Conditions such as Parkinson's disease, amyo- 
trophic lateral sclerosis (ALS), striato-nigral degeneration, the 
cerebellar degenerations, Hallevorden-Spatz disease and others, 
have no currently known etiology. They do, however, have 
in  common  the  specific,  highly  selective  degeneration  of 
neurons  in particular  neuroanatomic  systems. 
At  present,  we have no  evidence  that  such  an  NK cell- 
mediated system of neuronal destruction  is involved in any 
of the human neurodegenerative conditions.  Moreover,  the 
above mentioned diseases, save perhaps ALS (35, 36), are not 
currently believed to have an immunologically mediated patho- 
genesis. Nevertheless, four observations must be considered 
while  evaluating  the  possibility  that  some  human  neu- 
rodegenerative disorders might occur via an immunologically 
mediated mechanism: (a) In rat ganglia examined 2 mo after 
guanethidine-induced  cell destruction,  there is no evidence 
of an antecedent inflammation event. The ganglia are devoid 
of infiltrating lymphoid cells. Therefore, histological exami- 
nation  of  the  destroyed  neuronal  group  at  time  points 
significantly beyond the acute phase of injury may give no 
clue as to the mechanism causing the neuronal destruction. 
(b) In the guanethidine model of NK killing of neurons,  the 
exposure of all the target neurons to the offending substance 
is simultaneous, high in concentration, and regularly repeated 
over a short interval. In human disease, if such a mechanism 
is acting, the exposure of neurons to the offending agent might 
be selective within  a set of neurons,  of low dosage,  and ir- 
regularly administered over a protracted period of time.  (c) 
Guanethidine and its close analog guanacline are both known 
to produce SCG inflammatory neuronal killing in subhuman 
814  Natural Killer Cell-mediated Neuronal Killing Figure 2.  Ultrastructural  appearance of cells in the SCG 7 d after the initiation  of guanethidine  treatment. A large granuhted  lymphocyte  (L) has 
breeched the satellite  cell sheath and is intimately  apposed to the cell body of a principal sympathetic  neuron (N). The neuronal  cytoplasm  exhibits 
a diminished  content of Nissl substance and an accumulation  of a variety  of subcellular organelles, x6,600. 
primates (37),  further supporting the possibility that this 
pathogenetic pathway might be active in some human dis- 
eases. (d) Persistent orthostatic hypotension (a condition refer- 
able to autonomic/sympathetic  neuron dysfunction) has been 
reported in human patients given high doses of guanacline 
(38, 39),  although, the pathology and pathogenetic mecha- 
nism have not been described. 
The present report raises the possibility that one or more 
of the idiopathic human neurodegenerative diseases may de- 
velop via an exogenously induced, autoimmune, NK cell- 
mediated pathogenetic process heretofore not known to exist. 
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